HeCIT is a clinical stage biotech with an exciting portfolio of programs. We are committed to pioneering novel therapeutics to treat cancer, infectious and rare diseases. HeCIT aims to deliver formidable results to patients by acting in an agile and transparent manner and be recognized for its industry disruptive innovation in healthcare.